Last updated on May 2019

Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Patients With Schizophrenia


Brief description of study

The purpose of the study is to evaluate the efficacy, safety, and tolerability of different dose regimens of TV-46000 administered subcutaneously as compared to placebo during maintenance treatment in adult and adolescent patients with schizophrenia. The study will include male and female patients, 13 to 65 years of age, who have a confirmed diagnosis of schizophrenia, are clinically stable, and are eligible for risperidone treatment.

Clinical Study Identifier: NCT03503318

Find a site near you

Start Over

Teva Investigational Site 14772

Cedarhurst, NY United States
  Connect »

Teva Investigational Site 14819

San Marcos, CA United States
  Connect »

Teva Investigational Site 14794

Bellflower, CA United States
  Connect »

Teva Investigational Site 14833

Norristown, PA United States
  Connect »

Teva Investigational Site 14820

New Bedford, MA United States
  Connect »

Teva Investigational Site 14778

Charleston, SC United States
  Connect »

Teva Investigational Site 14815

Pico Rivera, CA United States
  Connect »

Teva Investigational Site 14771

National City, CA United States
  Connect »

Teva Investigational Site 14764

Glen Burnie, MD United States
  Connect »

Teva Investigational Site 14826

Creve Coeur, MO United States
  Connect »

Teva Investigational Site 14769

Little Rock, AR United States
  Connect »

Teva Investigational Site 14767

Costa Mesa, CA United States
  Connect »

Teva Investigational Site 14802

Costa Mesa, CA United States
  Connect »

Teva Investigational Site 14773

Culver City, CA United States
  Connect »

Teva Investigational Site 14835

Garden Grove, CA United States
  Connect »

Teva Investigational Site 14785

San Bernardino, CA United States
  Connect »

Teva Investigational Site 14836

Hallandale Beach, FL United States
  Connect »

Teva Investigational Site 14799

Lauderhill, FL United States
  Connect »

Teva Investigational Site 14810

North Miami, FL United States
  Connect »

Teva Investigational Site 14831

Orange City, FL United States
  Connect »

Teva Investigational Site 14805

Hoffman Estates, IL United States
  Connect »

Teva Investigational Site 14825

Shreveport, LA United States
  Connect »

Teva Investigational Site 14791

Saint Louis, MO United States
  Connect »

Teva Investigational Site 14790

Saint Louis, MO United States
  Connect »

Teva Investigational Site 14813

Saint Louis, MO United States
  Connect »

Teva Investigational Site 14780

Staten Island, NY United States
  Connect »

Teva Investigational Site 14763

Cincinnati, OH United States
  Connect »

Teva Investigational Site 14822

Oklahoma City, OK United States
  Connect »

Teva Investigational Site 14793

Downingtown, PA United States
  Connect »

Teva Investigational Site 14823

Long Beach, CA United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.